Global innovative perspectives and trends on digital health and patient safety: highlights from the #DHPSP2024 networking event
Sections
Open Access Original Article
Global innovative perspectives and trends on digital health and patient safety: highlights from the #DHPSP2024 networking event

Affiliation:

1Ludwig Boltzmann Institute Digital Health and Patient Safety, Medical University of Vienna, 1090 Vienna, Austria

2National University of Pharmacy of the Ministry of Health of Ukraine, 61002 Kharkiv, Ukraine

Email: hlitvinova@gmail.com

ORCID: https://orcid.org/0000-0003-1578-7398

Olena Litvinova
1,2*

Affiliation:

3Oral and Maxillofacial Radiology, Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China

ORCID: https://orcid.org/0000-0003-3672-357X

Andy Wai Kan Yeung
3

Affiliation:

4Departamento de Ciencias del Ambiente, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile

ORCID: https://orcid.org/0000-0002-1688-968X

Javier Echeverría
4

Affiliation:

5Department of Public Health, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan

ORCID: https://orcid.org/0000-0002-7830-6857

Yousef Khader
5

Affiliation:

6Laboratory of Environmental Health and Ecotoxicology, Department of Environmental Sciences, Jahangirnagar University, Dhaka 1342, Bangladesh

ORCID: https://orcid.org/0000-0002-5290-3821

Md. Mostafizur Rahman
6

Affiliation:

7Mechanical and Aerospace Engineering Department, College of Engineering, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates

ORCID: https://orcid.org/0000-0003-2376-9309

Zafar Said
7

Affiliation:

8Division of Medical Biology, Jan Kochanowski University, 25-406 Kielce, Poland

ORCID: https://orcid.org/0000-0002-4760-0690

Karolina Lach
8

Affiliation:

9Data Science, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India

10PM Research Center, Väpnaregatan 22, 58649 Linköping, Sweden

ORCID: https://orcid.org/0009-0002-6112-4835

Bhupendra Sidar
9,10

Affiliation:

11Department of Clinical Research, University of Southern Denmark (SDU), 5230 Odense, Denmark

12SATC-C, Department of Surgery, Svendborg Sygehus, Odense University Hospital (OUH), 5700 Svendborg, Denmark

13Department of Social Medicine & Public Health, Pomeranian Medical University (PUM), 70-204 Szczecin, Poland

ORCID: https://orcid.org/0000-0002-2248-489X

Anastasios Koulaouzidis
11,12,13

Affiliation:

14Indigenous Knowledge Systems Centre, Faculty of Natural and Agricultural Sciences, North-West University, Private Bag X2046, Mmabatho 2745, South Africa

15School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Durban 4041, South Africa

ORCID: https://orcid.org/0000-0002-6602-246X

Adeyemi O. Aremu
14,15

Affiliation:

16Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada

ORCID: https://orcid.org/0000-0002-5958-6961

Conrad V. Simoben
16

Affiliation:

17University Institute of Pharma Sciences, Chandigarh University, Mohali 140413, Punjab, India

ORCID: https://orcid.org/0000-0003-0803-4400

Hemanth Kumar Boyina
17

Affiliation:

18American Hospital Dubai, Dubai 5566, United Arab Emirates

ORCID: https://orcid.org/0009-0000-0335-5139

Firdous M. Usman
18

Affiliation:

19Institute for Physical Activity and Nutrition, Deakin University, Melbourne 3125, Australia

ORCID: https://orcid.org/0000-0001-7926-9368

Sheikh Mohammed Shariful Islam
19

Affiliation:

20Department of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University-Seoul, Goyangsi 10326, Republic of Korea

ORCID: https://orcid.org/0000-0003-4118-4355

Jayanta Kumar Patra
20

Affiliation:

20Department of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University-Seoul, Goyangsi 10326, Republic of Korea

ORCID: https://orcid.org/0000-0002-5676-0768

Gitishree Das
20

Affiliation:

21Electrodics and Electrocatalysis (EEC) Division, CSIR - Central Electrochemical Research Institute (CSIR - CECRI), Karaikudi 630003, Tamil Nadu, India

22Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India

ORCID: https://orcid.org/0000-0001-8059-7043

Ganesh Venkatachalam
21,22

Affiliation:

23Department of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai 602105, Tamil Nadu, India

ORCID: https://orcid.org/0000-0001-8867-7603

Hitesh Chopra
23

Affiliation:

24Institute of Sports Medicine, Prevention and Rehabilitation and Research Institute of Molecular Sports Medicine and Rehabilitation, Paracelsus Medical University, 5020 Salzburg, Austria

25REHA-Zentrum Salzburg, 5020 Salzburg, Austria

26Ludwig Boltzmann Institute for Digital Health and Prevention, 5020 Salzburg, Austria

ORCID: https://orcid.org/0000-0002-2811-9041

Josef Niebauer
24,25,26

Affiliation:

27Chemical Science and Engineering Research Team (ERSIC), Department of Chemistry, Polydisciplinary Faculty of Beni Mellal (FPBM), Sultan Moulay Slimane University (USMS), Beni Mellal 23000, Morocco

ORCID: https://orcid.org/0000-0001-8749-2009

Ahmed Fatimi
27

Affiliation:

28DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou Campus, 15780 Athens, Greece

ORCID: https://orcid.org/0000-0002-5971-0010

Alexandros G. Georgakilas
28

Affiliation:

29Department of Pharmaceutical Chemistry, Medical University of Gdańsk, 80-416 Gdańsk, Poland

ORCID: https://orcid.org/0000-0001-9907-9414

Mohammad Reza Saeb
29

Affiliation:

30Department of Plant Science, University of Buea, Buea P.O. Box 63, Cameroon

31Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany

ORCID: https://orcid.org/0009-0004-6884-8435

Doris E. Ekayen
30,31

Affiliation:

32Department of Pharmaceutical Chemistry, School of Pharmacy, University of Nairobi, Nairobi 00202, Kenya

ORCID: https://orcid.org/0000-0002-5395-7522

Kennedy O. Abuga
32

Affiliation:

33Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland

34Department of General, Gastroenterologic and Oncologic Surgery, Medical University of Warsaw, 02-097 Warsaw, Poland

Michał Ławiński
33,34

Affiliation:

35Tsinghua University, Beijing 100084, China

ORCID: https://orcid.org/0009-0001-1524-5583

Yue Qiu
35

Affiliation:

36UCD School of Chemical and Bioprocess Engineering, University College Dublin, D04 V1W8 Dublin, Ireland

ORCID: https://orcid.org/0000-0002-9737-6017

Eliana B. Souto
36

Affiliation:

37Vanke School of Public Health, Tsinghua University, Beijing 100084, China

ORCID: https://orcid.org/0000-0002-3626-7220

Guanqiao Li
37

Affiliation:

38Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan

ORCID: https://orcid.org/0000-0002-0509-1621

Hari Prasad Devkota
38

Affiliation:

39Institute for AI Industry Research, Tsinghua University, Beijing 100084, China

Weizhi Ma
39

Affiliation:

40Department of Chemistry, FMKMC College, Mangalore University Constituent College, Madikeri 571201, Karnataka, India

ORCID: https://orcid.org/0000-0002-0393-2474

Jamballi G. Manjunatha
40

Affiliation:

41Department of Biochemical Pharmacology and Drug Design, Institute of Molecular Biology “Roumen Tsanev”, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria

ORCID: https://orcid.org/0000-0002-8482-0481

Nikolay T. Tzvetkov
41

Affiliation:

42Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida 201303, Uttar Pradesh, India

ORCID: https://orcid.org/0000-0001-5580-5410

Rupesh K. Gautam
42

Affiliation:

33Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland

ORCID: https://orcid.org/0009-0001-5388-6285

Maima Matin
33

Affiliation:

43Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, 01-938 Warsaw, Poland

ORCID: https://orcid.org/0000-0003-1875-2510

Olga Adamska
43

Affiliation:

44Department of Biochemical Sciences, Pomeranian Medical University, 71-460 Szczecin, Poland

ORCID: https://orcid.org/0000-0001-8340-9423

George Koulaouzidis
44

Affiliation:

45Department of Pharmacy, East West University, Dhaka 1212, Bangladesh

ORCID: https://orcid.org/0009-0001-9163-6551

Farhan Bin Matin
45

Affiliation:

46Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne 3004, Australia

ORCID: https://orcid.org/0000-0002-9224-113X

Bodrun Naher Siddiquea
46

Affiliation:

47Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario L8S 4L8, Canada

ORCID: https://orcid.org/0000-0002-6195-4428

Dongdong Wang
47

Affiliation:

48Swiss Paraplegic Research, CH-6207 Nottwil, Switzerland

ORCID: https://orcid.org/0000-0001-6842-6284

Jivko Stoyanov
48

Affiliation:

33Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland

ORCID: https://orcid.org/0000-0002-7561-0941

Jarosław Olav Horbańczuk
33

Affiliation:

33Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland

ORCID: https://orcid.org/0000-0001-9479-3985

Kamil Wysocki
33

Affiliation:

1Ludwig Boltzmann Institute Digital Health and Patient Safety, Medical University of Vienna, 1090 Vienna, Austria

49Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria

ORCID: https://orcid.org/0000-0001-6744-0949

Emil D. Parvanov
1,49

Affiliation:

33Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland

ORCID: https://orcid.org/0000-0002-4186-4900

Michel-Edwar Mickael
33

Affiliation:

33Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland

ORCID: https://orcid.org/0000-0001-5546-9891

Artur Jóźwik
33

Affiliation:

33Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland

ORCID: https://orcid.org/0009-0003-2324-7911

Natalia Ksepka
33

Affiliation:

50Department of Chemistry, Faculty of Science, University of Buea, Buea P.O. Box 63, Cameroon

51Department of Microbial Bioactive Compounds, Interfaculty Institute for Microbiology and Infection Medicine, University of Tübingen, 72076 Tübingen, Germany

ORCID: https://orcid.org/0000-0002-4476-5860

Smith B. Babiaka
50,51

Affiliation:

52Sunway Biofunctional Molecules Discovery Centre (SBMDC), School of Medical and Life Sciences, Sunway University, Sunway City 47500, Malaysia

53Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo 2007, Australia

ORCID: https://orcid.org/0000-0003-1006-3649

Bey Hing Goh
52,53

Affiliation:

54Singapore National Eye Center, Singapore Eye Research Institute, 168751, Singapore

55Duke-NUS Medical School, National University of Singapore, 119077, Singapore

56Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing 100084, China

57School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 100084, China

ORCID: https://orcid.org/0000-0002-8448-1264

Tien Yin Wong
54,55,56,57

Affiliation:

58Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

59Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

ORCID: https://orcid.org/0000-0003-4515-8090

Benjamin S. Glicksberg
58,59

Affiliation:

60Department of Electrical Engineering and Information Technology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540142 Târgu Mureș, Romania

ORCID: https://orcid.org/0000-0001-6254-9291

Laszlo Barna Iantovics
60

Affiliation:

61Orthopaedic and Rehabilitation Department, Medical University of Warsaw, 02-091 Warsaw, Poland

Marcin Łapiński
61

Affiliation:

61Orthopaedic and Rehabilitation Department, Medical University of Warsaw, 02-091 Warsaw, Poland

ORCID: https://orcid.org/0000-0002-5633-8153

Artur Stolarczyk
61

Affiliation:

62Ethnopharmacology & Zoopharmacognosy, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany

63Department of Agriculture and Food Sciences, Neubrandenburg University of Applied Sciences, 17033 Neubrandenburg, Germany

ORCID: https://orcid.org/0000-0003-1904-2430

Fabien Schultz
62,63

Affiliation:

64Department of Systems Medicine and Bioengineering, Houston Methodist Cancer Center and T. T. and W. F. Chao Center for BRAIN, Houston Methodist Academic Institute, Houston Methodist Hospital, Houston, TX 77030, USA

65Departments of Radiology, Pathology and Laboratory Medicine and Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA

ORCID: https://orcid.org/0000-0001-9188-6502

Stephen T. Wong
64,65

Affiliation:

66Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-5158, USA

67Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-5158, USA

ORCID: https://orcid.org/0000-0001-9668-3368

Ronan Lordan
66,67

Affiliation:

68Emirates Health Services, Al Amal Psychiatric Hospital, Dubai P.O. Box 2299, United Arab Emirates

ORCID: https://orcid.org/0000-0002-0701-7628

Faisal A. Nawaz
68

Affiliation:

69Department of Pharmacy and Institutes for Systems Genetics, Center for High Altitude Medicine, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China

70School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India

ORCID: https://orcid.org/0000-0002-3353-7897

Rajeev K. Singla
69,70

Affiliation:

71School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai 600119, Tamil Nadu, India

ORCID: https://orcid.org/0000-0002-2483-7679

ArunSundar MohanaSundaram
71

Affiliation:

72Department of Physiology, All India Institute of Medical Science, Deoghar 814152, Jharkhand, India

ORCID: https://orcid.org/0000-0001-6950-5857

Himel Mondal
72

Affiliation:

72Department of Physiology, All India Institute of Medical Science, Deoghar 814152, Jharkhand, India

ORCID: https://orcid.org/0009-0008-1340-6655

Ayesha Juhi
72

Affiliation:

73Department of Physiology, Raiganj Government Medical College, Raiganj 733134, West Bengal, India

ORCID: https://orcid.org/0000-0001-5027-4657

Shaikat Mondal
73

Affiliation:

74Independent Researcher, 71000 Sarajevo, Bosnia and Herzegovina

ORCID: https://orcid.org/0000-0003-0719-7240

Merisa Cenanovic
74

Affiliation:

75Medical University of Graz, 8010 Graz, Austria

Elisa Opriessnig
75

Affiliation:

76European Student Think Tank, Public Health and Policy Working Group, 1058 DE Amsterdam, Netherlands

ORCID: https://orcid.org/0000-0002-4250-574X

Christos Tsagkaris
76

Affiliation:

77Independent Researcher, Kolkata 700019, West Bengal, India

ORCID: https://orcid.org/0000-0002-1469-6139

Ronita De
77

Affiliation:

78Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

ORCID: https://orcid.org/0000-0002-3037-3014

Siva Sai Chandragiri
78

Affiliation:

79Faculty of Applied Mathematics, Silesian University of Technology, 44-100 Gliwice, Poland

ORCID: https://orcid.org/0000-0001-9990-1084

Robertas Damaševičius
79

Affiliation:

80Department of Medicine, University of Salerno, 84081 Salerno, Italy

ORCID: https://orcid.org/0000-0002-5236-3132

Marco Cascella
80

Affiliation:

81Interdisciplinary Department of Medicine, School of Medicine, University of Bari “Aldo Moro”, 70124 Bari, Italy

ORCID: https://orcid.org/0000-0001-6521-8578

Giuseppe Lisco
81

Affiliation:

81Interdisciplinary Department of Medicine, School of Medicine, University of Bari “Aldo Moro”, 70124 Bari, Italy

ORCID: https://orcid.org/0000-0001-6308-0528

Vincenzo Triggiani
81

Affiliation:

82Division of Endocrinology, Diabetology and Clinical Nutrition, Sant’Anna Hospital - ASST Lariana, 22042 Como, Italy

ORCID: https://orcid.org/0000-0002-9369-2629

Olga Eugenia Disoteo
82

Affiliation:

1Ludwig Boltzmann Institute Digital Health and Patient Safety, Medical University of Vienna, 1090 Vienna, Austria

33Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland

83Laboratory of Natural Products and Medicinal Chemistry (LNPMC), Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 602105, Thandalam, India

84Patient Safety & Digital Health (PaDiH) Group, Fakultät Medizin/Zahnmedizin, Danube Private University, 3500 Krems-Stein, Austria

Email: atanas.atanasov@lbg.ac.at

ORCID: https://orcid.org/0000-0003-2545-0967

Atanas G. Atanasov
1,33,83,84*

Explor Digit Health Technol. 2025;3:101166 DOI: https://doi.org/10.37349/edht.2025.101166

Received: January 22, 2025 Accepted: July 22, 2025 Published: October 16, 2025

Academic Editor: Zhaohui Gong, Ningbo University, China

Abstract

Aim: This manuscript summarizes the key scientific and practical outcomes of the #DHPSP2024 digital networking event, focusing on emerging trends in digital health technologies, innovations in patient safety, and their implications for improving healthcare delivery.

Methods: The #DHPSP2024 event was held from June 18 to 20, 2024, on X (formerly Twitter) and LinkedIn, connecting professionals and stakeholders in digital health and patient safety from different sectors. Data from posts on X and LinkedIn were analyzed for geographical distribution, engagement metrics (impressions, likes, shares), top hashtags, and frequently used terms. A qualitative analysis of the central themes and key online messaging discussions of the network event was also conducted.

Results: On X, 2,329 posts by 179 participants from 38 countries generated over 231,000 impressions, with the most activity in Austria, China, and India. LinkedIn engagement included 3,475 likes, 217 comments, and 2,030 shares. Both platforms highlighted core themes such as digital health, patient safety, treatment quality, research on natural compounds, and interdisciplinary collaboration. Online messaging discussions emphasized technologies like telemedicine and artificial intelligence as critical tools for enhancing care delivery and patient safety. Participants also promoted special issues of scientific journals and explored collaborative research opportunities.

Conclusions: The #DHPSP2024 event underscored the pivotal role of digital technologies in transforming healthcare, particularly in improving the quality and safety of interventions. The findings demonstrate how digital networking events, grounded in open innovation, foster global research communities, accelerate knowledge exchange, and support the integration of clinically relevant digital solutions. The strong engagement reflects growing interest in leveraging digital platforms to advance health outcomes and professional development. Overall, the event contributed to greater visibility of ongoing research, encouraged interdisciplinary cooperation, and may positively influence both the adoption of innovations in healthcare practice and the dissemination of scientific knowledge.

Keywords

academic networking, digital health, healthcare hashtags, innovation, LinkedIn, patient safety, social media, X (formerly Twitter)

Introduction

Digital health is a rapidly growing research area, with a vast amount of evidence accumulated in recent years to better understand the mechanisms of human diseases and improve their diagnosis and treatment. Today, it is widely acknowledged that digitalization contributes and will continue to contribute significantly to solving many health challenges [1, 2]. Digital health is closely related to different fields of experimental and practical medicine, and it is of high importance for ensuring patient safety. Digitalization reduces the likelihood of errors and improves the quality of care and monitoring of patients, optimizing the processes of prevention, diagnosis, and treatment of diseases [38].

In particular, digital tools can improve diagnostic accuracy (for example, using AI algorithms [9]), provide continuous monitoring of patient physiological parameters through wearable devices, automate adherence control, and implement telemedicine solutions to provide access to care in remote regions. These approaches are aimed at solving systemic health problems, including a shortage of personnel, overload of institutions, an increase in chronic diseases, an aging population, etc. [2].

According to the World Health Organization (WHO) Global patient safety report (2024), unsafe health care is a major global problem affecting more than 10% of patients and causing millions of deaths, as well as significant economic losses, especially in low- and middle-income countries. Improving patient safety can significantly reduce costs and improve the cost-effectiveness of healthcare, with the potential for annual savings of up to $1.17 trillion [10].

To improve patients’ safety, WHO has included the adoption of digital technologies in its Global Action Plan 2021–2030. The plan also emphasizes the implementation of open and transparent reporting systems that identify the causes of incidents, learn from mistakes, and prevent their recurrence, contributing to enhanced patient safety and healthcare efficiency. These processes are made more efficient through digital communication tools that support information exchange, accelerate the implementation of innovative solutions, and promote the spread of “open innovation” [11]. Furthermore, one of the objectives of the Global Digital Health Strategy 2020–2025 is to foster global collaboration and support the transfer of knowledge in the field of digital health [12].

Open innovations stimulate the development and implementation of new solutions in healthcare [1315]. Thus, the creation of open digital platforms plays a crucial role in supporting innovative approaches to ensuring patient safety and the effective prevention and treatment of diseases. For example, the Digital Health and Patient Safety Platform (DHPSP) has been developed and implemented. This open innovation initiative facilitates collaborative research and the development of digital solutions to enhance patient safety [16]. Another significant example from the health sciences domain is the open innovation platform “International Natural Product Sciences Taskforce” (INPST), which brings together researchers in the field of natural product studies [17].

Within the framework of open digital medical platforms, researchers are actively using additional formats of conferences, network events with the involvement of social networks (X (Twitter), LinkedIn, etc.), and the use of hashtags, which facilitate knowledge exchange and stimulate discussions on innovative healthcare solutions [1823]. Despite the obvious benefits of social media, its unique potential requires further study and dissemination to physicians and patients worldwide.

At the same time, online events specifically related to digital health and patient safety using social networks have not been broadly implemented up to now. In this regard, a networking event, DHPSP2024, was held from June 18 to 20, 2024, using a variation (#DHPSP2024) of the conventional hashtag (#DHPSP) of the DHPSP on the social networks X and LinkedIn. The organizers encouraged the use of the hashtag #DHPSP2024 to connect and engage digital health and patient safety professionals in expanding their professional network.

This paper offers something new in the form of a structured analysis of digital health networking activities across two of the most important social media platforms, X and LinkedIn, and understanding how professional and stakeholder communities engage and diffuse knowledge in this area. Although various other studies have addressed either one of these platforms at a time or a particular event, the added power of real-time digital engagement with cross-platform synergies in professional networking is underlined. Further, the findings go beyond the traditional academic metrics through a study of how hashtags, impressions, and qualitative themes can also be used when analyzing the virtual event for creating a global collaboration of innovation. Thus, this study aims to summarize the outcomes of the #DHPSP2024 digital networking event and systematically analyze the relevant posts that were shared in the frame of this event on X and LinkedIn. Particular attention is paid to identifying new trends in digital medical technologies, innovations in patient safety, and their impact on improving treatment efficiency.

Materials and methods

The digital networking event #DHPSP2024 was held from June 18 to 20, 2024, bringing together digital health and patient safety professionals. The organizing committee of the network event was headed by Dr. Atanas G. Atanasov. Participants were encouraged to share relevant messages through their profiles on X or LinkedIn, mentioning the hashtag #DHPSP2024, while the use of additional relevant hashtags was not discouraged. Topical issues of digital health and patient safety led to the following main proposed areas for interaction: demonstration of own research by participants; collaboration calls (“Searching for collaboration partners to do joint work on...”); jobs; announcements of special issues of journals; announcements of conferences, seminars, or lectures; linking to relevant new publications; presentation of products, services, or developed technologies; and other types of communications related to digital health or patient safety.

The event was attended by representatives of the academic community, medical specialists, digital solutions developers, representatives of the editorial board of scientific journals, and other stakeholders. Such an intersectoral composition ensured the versatility of the topics discussed and expanded the range of digital initiatives presented.

The social network X was used to extract data on posts associated with the hashtag #DHPSP2024 from March 6 to July 6, 2024. This made it possible to take into account the activity of participants before, during, and after the #DHPSP2024 event to ensure an understanding of the dynamics of participant engagement, including preparation for the event, discussions in the process, and reactions after its completion. Tweets containing this hashtag were analyzed using the Fedica (https://fedica.com/) tool as of 06.07.2024. An analysis of the geographical distribution of tweets, impressions, the most popular hashtags, and key terms was carried out. Analogic analysis of posts containing #DHPSP2024 was also done on the LinkedIn social network as of July 6, 2024. LinkedIn posts were also analyzed for the most popular hashtags and key terms.

The following steps were taken to analyze Х and LinkedIn data. First, after uploading the CSV files containing the tweet or LinkedIn data, the text was processed by removing URLs and special characters and converting it to lowercase. After splitting the text into individual words, common English stop words were excluded using the NLTK library in Python. Thereafter, the occurrences of each word were counted and hashtags from tweets or LinkedIn data posts were identified. Additionally, pairs of hashtags that frequently appeared together were analyzed in the Х dataset. The fifty most frequently occurring words, hashtags, and co-occurring hashtag pairs were also identified.

In addition to the quantitative analyses described above, a qualitative content analysis was incorporated to enrich the study’s analytical design. The content of #DHPSP2024 posts was reviewed to identify recurring themes and contextual details beyond word frequencies, with posts categorized according to the predefined areas of interaction (e.g., personal research sharing, collaboration calls, new technology presentations) that guided the event. Through manual examination, it became possible to connect specific digital health technologies mentioned to their relevant healthcare domains, rather than just listing them.

For instance, this process allowed a connection between discussions of telemedicine applications and the context of patient care, or a relation of mentions of AI tools to the medical fields they aim to improve. This mixed-methods approach (combining quantitative metrics with qualitative thematic analysis) provided both a broad overview of social media engagement and deeper insight into how participants framed digital health innovations in practice.

The extraction and analysis of data from X (formerly Twitter) and LinkedIn were conducted by a core team of two researchers (AGA and MEM), with two additional contributors assisting in qualitative review (OL and MM). Data processing was initiated by the lead authors, who exported content using the Fedica platform (for X) and LinkedIn analytics tools. To ensure analytical rigor, both platforms’ datasets were independently reviewed by at least two researchers each. Discrepancies in coding, thematic classification, or interpretation were resolved through group discussion and consensus among the four researchers. Cross-validation of themes and metrics (e.g., top hashtags, engagement rates, word frequency) was performed to ensure consistency. The decision on which topics to report in the results was guided by relevance to digital health and patient safety, frequency of appearance, and potential scientific or practical significance. A final agreement on themes and their categorization was reached through iterative discussions among all involved authors. The key themes that emerged and are flagged in the Results and Discussion sections include: (1) telemedicine and AI in diagnostics and care, (2) digital pharmacovigilance and health sensors, (3) social media in medical education and communication, (4) digital twins and virtual platforms for care planning, and (5) patient safety initiatives and global engagement with digital health innovations.

All data is presented anonymously in compliance with the General Data Protection Regulation (GDPR), without mentioning specific accounts.

Results

An analysis of the posts using the hashtag #DHPSP2024 on the social media platform X revealed a significant level of engagement and geographic diversity among participants in the study period. A total of 2,329 posts were published by 179 participants from 38 countries, generating over 231,000 impressions.

The distribution of posts with #DHPSP2024 by the countries most actively participating in the discussion is shown in Figure 1. These findings suggest a global interest in the topic of digital health and patient safety, extending across various regions. Thus, the digital networking event #DHPSP2024 has gained widespread recognition.

Distribution of X accounts participating in the #DHPSP2024 network event ranked by country.

Austria, China, and India took the first three positions. The high activity of participants from these countries may be due to the involvement of their researchers in organizing the event and professional activity in the field of digital health. In addition, these countries are characterized by high institutional support for the development of digital medical technologies, developed digital infrastructure, government support for digitalization, and strong academic and research clusters that contribute to the promotion of relevant initiatives.

An analysis of the time of posting activity of users of the social network X using the hashtag #DHPSP2024 revealed its peak from June 18 to June 20, 2024, coinciding with the network event.

The #DHPSP2024 online event on LinkedIn garnered 3,475 likes, 217 comments, 2,030 shares, and reached overall 5,722 engagements, demonstrating high participant activity and wide reach.

The primary objective of the conference was to bring together individuals and organizations interested in the state of modern digital health and patient safety. In connection with this, an analysis of the #DHPSP2024 posts was carried out to find the most common words and hashtags on the social networks X and LinkedIn.

X data analysis reveals the focus on digital health

The collected X data emphasizes digital health and patient safety, with frequent mentions of “digital” and “health,” indicating a focus on technological advancements. “Patient” and “safety” are also prominent, highlighting discussions on care quality. Networking and research are key themes, as seen in terms like “networking,” “technologies,” and “research.” The use of words like “share,” “study,” and “article” suggests a research focus and collaborative effort to improve health outcomes. Along the same line, mentions of “journal,” “book,” and “papers” reflect a commitment to academic contributions and knowledge dissemination (Table 1, Figure 2).

 Fifty most common words of the #DHPSP2024 posts on X.

RankWordCountRankWordCount
1digital1,52826journal142
2health1,50627book136
3patient91028disease132
4safety90229promote130
5networking28630potential130
6healthcare28431papers128
7technologies27632AI128
8event27233data128
9care25634cancer126
10review23635drug124
11special21636new124
12issue21437global124
13published20438glad122
14study20439systems118
15future20040twitter116
16share19641sharing110
17analysis18842intelligence110
18research18643technology106
19article17844role104
20online16845views102
21dive16446patients100
22June15647connect100
23improving15248collaborate100
24access15249tools98
25applications15050conference98

Word cloud of the 50 most common words revealed from the X datasets analysis of the #DHPSP2024 posts.

Analysis of the word counts from Table 1 using the Lilliefors goodness-of-fit test reveals a departure from normality, which was additionally validated by using the Q-Q plot (Figure 3). The search for extremes, Figure 4, identified values associated with the words ranked on the first four positions (digital, health, patient, safety) as statistically significant extremes that proved the principal focus of the digital networking event.

Quantile-Quantile (Q-Q) plot assessing the normality of word counts from Table 1.

Box Plot highlighting extreme word frequencies from Table 1.

Thus, the results indicate that the networking events attracted focus on words related to academia and networking as well as digital health. Moreover, our 50 most common hashtag analysis supports the evidence that the networking event was successful in focusing on patient digital health.

The X hashtag data highlights a strong focus on digital health and patient safety, with #DHPSP2024, #DigitalHealth, and #PatientSafety leading the conversation (Table 2). The top hashtags emphasize the importance of healthcare innovations and patient well-being. Hashtags like #SciComm and #INPST underscore the value of scientific communication and research collaboration. The dataset also reveals discussions around specific health issues, with hashtags like #Telehealth, #Dementia, and #NutritionFacts indicating targeted topics. Overall, the data reflect an active community engaged in promoting digital health advancements and enhancing global healthcare practices (Table 2).

 50 most common hashtags of the #DHPSP2024 posts on X, sorted by number of occurrences.

RankWordCountRankWordCount
1#DHPSP202467726#mdpifoods17
2#DigitalHealth34727#ExplorDHT17
3#PatientSafety23528#EUPSA17
4#INPST12629#DHPS16
5#DHPSP11530#cancer16
6#Gratitude6331#Dementia15
7#SciComm6332#NutritionFacts15
8#digitalhealth3433#some4pedsu15
9#NPMND3334#Alzheimer14
10#mdpiantioxidants2735#cardioed14
11#WHO2736#diabetes14
12#Hungary2437#DIgitalHealth14
13#DHPSP22438#DigitalHe14
14#Momo2339#DigitalHeal14
15#WorldRefugeeDay2140#neuro13
16#WithRefugees2141#Machinelearning12
17#Croatia2142#Digitalhealth12
18#Modric2143#Health12
19#Binance2144#HealthTech12
20#IGJPS2045#SCINATMED11
21#mdpicimb2046#SCICADD11
22#ArdaGuler2047#Springer11
23#Telehealth1948#Book11
24#Healthcare1949#Diet11
25#Hospital1850#HealthInformation10

Analysis of the word counts from Table 2 using the Lilliefors test confirmed the departure from normality initially observed in Table 1 and Figures 3 and 4.

Our analysis reveals that the digital event created attention toward various networking aspects, such as healthcare innovations, scientific communication, with many underlying topics addressed such as nutrition and disease pathologies such as dementia.

Common co-occurring hashtags reveal various aspects of the networking event impact

The co-occurring hashtag data from the X posts reveal a strong emphasis on digital health and patient safety, with #DHPSP2024 frequently paired with #DigitalHealth and #INPST (Table 3). These combinations highlight ongoing initiatives in healthcare innovation and safety measures. Hashtags like #INPST and #SciComm are also commonly associated, underscoring the importance of research and scientific communication. The presence of #Gratitude and #WithRefugees indicates broader community engagement and support for global causes. This dataset reflects a vibrant X community actively discussing health advancements and social issues, fostering collaboration and awareness across diverse topics.

 50 most common co-occurring hashtag pairs of the #DHPSP2024 posts on X.

RankHashtag 1Hashtag 2CountRankHashtag 1Hashtag 2Count
1#DHPSP2024#DigitalHealth15826#DHPSP2024#WithRefugees21
2#PatientSafety#DigitalHealth13027#Croatia#Momo21
3#DHPSP2024#INPST11628#Croatia#DigitalHealth21
4#PatientSafety#DHPSP20249129#Croatia#Modric21
5#DHPSP2024#DHPSP8530#Croatia#Binance21
6#DHPSP2024#Gratitude6331#Hungary#WithRefugees21
7#SciComm#Gratitude6332#Hungary#DigitalHealth21
8#DHPSP2024#SciComm6333#Hungary#Modric21
9#INPST#DHPSP6034#Hungary#Binance21
10#digitalhealth#DHPSP20243435#Croatia#WithRefugees21
11#DHPSP2024#NPMND2636#WithRefugees#Momo21
12#NPMND#DHPSP2537#WithRefugees#DigitalHealth21
13#Hungary#DHPSP20242438#Modric#WithRefugees21
14#NPMND#INPST2439#Binance#WithRefugees21
15#DHPSP2024#Momo2340#Croatia#Momo21
16#Hungary#Momo2341#Croatia#DigitalHealth21
17#DHPSP2024#AI2242#Croatia#Modric21
18#DHPSP2024#WorldRefugeeDay2143#Croatia#Binance21
19#Hungary#WorldRefugeeDay2144#DigitalHealth#Momo21
20#WithRefugees#WorldRefugeeDay2145#Modric#Momo21
21#Croatia#WorldRefugeeDay2146#Binance#Momo21
22#WorldRefugeeDay#Momo2147#Modric#DigitalHealth21
23#WorldRefugeeDay#DigitalHealth2148#Binance#DigitalHealth21
24#Modric#WorldRefugeeDay2149#Binance#Modric21
25#DHPSP2024#WithRefugees2150#ArdaGuler#WorldRefugeeDay20

Interestingly, the event surpassed the boundaries of academic networking to engage with global causes, as evidenced by the World Refugee Day hashtag occurring alongside the networking event main hashtag.

Analysis of the word counts from Table 3 using the Lilliefors test also revealed the same departure from normality.

Analysis of the LinkedIn #DHPSP2024 posts dataset

The LinkedIn data highlights a strong emphasis on health and technology, with prominent words like “health”, “digital”, and “healthcare” leading the conversation (Table 4, Figure 5). The frequent mentions of “research”, “patient”, and “safety” indicate a focus on advancing healthcare practices and ensuring patient well-being. Terms such as “data”, “technologies”, and “AI” (abbreviation from “artificial intelligence”) reflect the integration of digital tools in health solutions. The presence of words like “journal”, “study”, and “information” underscores the importance of knowledge sharing and research dissemination. Additionally, “networking”, “platform”, and “professionals” emphasize community engagement and collaboration. Overall, the data showcases a vibrant LinkedIn community dedicated to exploring the future of healthcare and technology (Table 4, Figure 5).

 Words sorted by occurrence.

RankWordCountRankWordCount
1health20726issue24
2digital15527special23
3healthcare11428twitter23
4research7729support23
5patient7330networking23
6safety4831technology22
720244332mental22
8care3833june22
9patients3634systems21
10online3435quality20
11data3436linkedin20
12journal3337researchers20
13social3238intervention20
14join3139application19
15technologies2940review18
16information2941clinical18
17X2842access18
18future2743treatment18
19study2744professionals18
20AI2645insights18
21potential2646work18
22platform2647science18
23medical2548monitoring17
24analysis2549medicine17
25impact2550outcomes17

Word cloud of the most occurring words in the #DHPSP2024 posts on LinkedIn supports the diverse topic areas discussed during the networking event.

Analysis of the word counts from Table 4 using the Lilliefors test also reveals the respective departure from normality.

Interestingly, LinkedIn data analysis showed a considerable outreach toward practical topics related to medical research, such as “mental health”, “researcher”, “patient”, and “intervention”.

50 most common hashtags of the LinkedIn posts

The LinkedIn data showcases a diverse array of hashtags, with a significant focus on health and technology (Table 5, Figure 6). The most frequently used hashtags are #DHPSP2024, #DHPSP, and #DigitalHealth, indicating a strong emphasis on digital health and patient safety. Other notable hashtags include #PatientSafety, #ExplorDHT, and #healthcare, underscoring the importance of healthcare and patient well-being. Additionally, there’s a presence of hashtags related to professional and academic communities such as #INPST, #NPMND, and #IIST. The data also highlights interests in specific fields like #physiotherapy, #NutritionFacts, and #DataScience. The variety of hashtags, including those with just one mention, like #technology, #telehealth, and #AI, reflects a broad engagement with topics spanning health, technology, and professional development on LinkedIn (Table 5, Figure 6).

 The most common hashtags of the LinkedIn #DHPSP2024 posts, sorted by occurrence rate.

RankHashtagCountRankHashtagCount
1#DHPSP20244926#HealthInformation1
2#DHPSP1727#telehealth1
3#DigitalHealth1528#Biobased1
4#INPST1429#Participated1
5#PatientSafety930#Resource1
6#ExplorDHT931#SIG1
7#NPMND332#nursing1
8#healthcare333#Delivered1
9#physiotherapy234#Book1
10#NutritionFacts235#CRC1
11#Happy236#Taylor1
12#IIST237#International1
13#IIMR238#Nutrition1
14#health239#BMC1
15#digitalhealth240#Springer1
16#PsychTwitter241#Frontiers1
17#DataScience242#IIP1
18#HealthInvestment143#Serve1
19#APTI144#AI1
20#Delight145#Healthcare1
21#CMC146#IACAPAP20241
22#Bentham147#YouthMentalHealth1
23#technology148#mHealth1
24#Indian149#EHealth1
25#Team150#Socialmedia1

Word cloud of the 50 most common LinkedIn hashtags of the #DHPSP2024 posts.

Similarly to the data from Tables 14, analysis of the word counts from Table 5 using the Lilliefors test also reveals the departure from normality.

Taken together, the data analysis of X versus LinkedIn data could indicate that although both events share a common theme, they also differentiate into distinctive areas of influence.

Qualitative analysis of the content revealed the dominant thematic clusters, among which the most frequent were telemedicine as a way to ensure continuous patient care, the use of AI in the diagnosis and prediction of diseases, the use of digital sensors in monitoring chronic conditions, and the introduction of digital pharmacovigilance systems and tools based on “digital twins” for modeling public health, etc.

Discussion

The systematization of the data obtained and summing up the results showed that the participants appreciated digital health as an area that is actively developing and improving. The network event provided an excellent opportunity for scientists from different countries to establish and strengthen cooperation in the field of digital health and patient safety.

A comparative analysis of the data with X and LinkedIn shows that both platforms focus on digital health and patient safety, but have different orientations. Posts on both social media platforms use the hashtags #DigitalHealth, #PatientSafety, and #INPST, but X posts are more oriented towards science communication (#SciComm) and LinkedIn posts are more oriented towards professional issues (e.g., #DataScience). X posts highlight social topics such as support for refugees (#WithRefugees), while LinkedIn posts focus on professional and research issues. Both platforms contribute to networking, aiming at the advancement of digital health.

The following section describes a number of themes of the #DHPSP2024 posts on the main directions of a network event for purposes of illustration, not limitation.

Posts about personal research and new publications

General issues of digital health

As part of the network event, general and private issues of digital health were discussed. One of the prominent discussions on general health issues was, for example, a post on the analysis of the 100 most significant publications on digital and mobile health. The study not only showed key areas of development, but also confirmed that technologies improve the quality of life of people (treatment of depression, control of diabetes, or support for patients with COVID-19, etc.). Such bibliometric analyses are important for tracking trends and directions in digital health as well as other research areas [2426].

Along with the above is an analysis of the main barriers to the use of digital technologies in healthcare, including infrastructure problems, psychological obstacles, and concerns about increasing workload. At the same time, training and perceptions of the effectiveness of technology and multisectoral incentives contribute to greater digital decision-making by health professionals [27].

Participants in the network event noted the impact of the COVID-19 pandemic on the development of digital technologies. Three categories of digital health are identified: telemedicine, digital access tools, and digital monitoring, improving health services and helping health systems adapt to the post-pandemic world [28].

Digital healthcare perspectives, including cloud computing, artificial intelligence/machine learning (AI/ML) advances, and wearable sensors automating many aspects of healthcare, driving the development of personalized medicine, are also presented. Concerns of healthcare workers and patients were noted [29].

Perspectives on the use of social media in health care

Participants also considered the prospects for using social networks as a tool for scientific communication and the promotion of knowledge in medicine. So, Х has become an important platform for sharing knowledge. It is noted that changes in its management raise concerns [30]. Along this line, hashtags such as #PsychTwitter and #NutritionFacts have contributed to the global promotion of topical aspects of psychiatry and nutrition information, reaching millions of users [31, 32].

Diagnosis using digital technologies

Participants also presented the latest information on the possibilities of diagnostics using AI and ML. In ophthalmology, AI has been reported to show potential for early screening for dry eye syndrome [33]. In oncology, the MRD-EDGE platform, using ML, enables blood levels of circulating tumor DNA (ctDNA) to be monitored in a variety of cancer types, including lung cancer and melanoma. This approach eliminates the need to analyze tumor tissues, which is important for patients on immunotherapy [34].

Telemedicine

Telemedicine also caught the attention of the participants at the #DHPSP2024 digital networking event. In particular, it was reported that during the COVID-19 pandemic, telecardiology contributed to the continuity of treatment and prevention of cardiovascular diseases [35, 36]. The readiness of medical staff to use telemedicine solutions in intensive care units was also discussed, with simplicity and alignment with current workflows being key factors for successful integration [37].

The mention of telecardiology being used during the COVID-19 pandemic to maintain care continuity [35, 36] underscores how telemedicine enabled critical cardiovascular services to continue despite lockdowns, directly contributing to patient safety. Participants’ discussions of staff readiness for tele-ICU systems highlighted that simplicity and alignment with existing workflows are key for successful integration of telemedicine in intensive care settings [37]. This emphasizes the practical considerations required for digital solutions to be effective in real-world healthcare environments.

Digital twin technologies in healthcare

An important issue has also become the relevance of the use of digital twin technologies to optimize mass vaccination and disease monitoring, despite the economic, social, and ethical challenges [38].

The discussion on digital twin technology for vaccination and disease monitoring illustrated its potential in public health planning. For example, a digital twin of a patient population can simulate different vaccination rollout scenarios to optimize coverage and predict outcomes, enhancing preparedness. Despite this optimism, participants noted significant economic, social, and ethical challenges in implementing such large-scale digital simulations [38]. This indicates that while digital twin approaches are promising, their real-world application requires careful navigation of those challenges.

Internet of medical things: digital sensors in medicine

The network event covered topics related to the Internet of Medical Things (IoMT), particularly in the context of developing digital sensors for continuous disease monitoring. It was emphasized that recent studies and patent trends demonstrate progress in creating non-invasive devices for monitoring glucose levels and blood pressure, significantly improving the management of chronic diseases such as diabetes and hypertension [39, 40]. These regulatory-approved technologies open new opportunities for personalized and effective patient treatment. The importance of digital health for children with type II diabetes in schools was also discussed. A digital platform was highlighted that helps regulate deep sleep and monitor glucose levels, improving the health and well-being of patients [41]. Digital pills with ingestible sensors can enhance treatment in areas such as mental health, HIV/AIDS, pain management, cardiology, and oncology, improve adherence to prescriptions, and reduce healthcare costs [42].

In the context of IoMT, participants highlighted the development of smart sensors for continuous disease monitoring. For instance, wearable devices that continuously track blood glucose or cardiac rhythms were mentioned as examples of IoMT innovations enabling real-time patient monitoring. Such examples demonstrate how IoMT can facilitate early detection of health anomalies and improve long-term management of chronic conditions by connecting patients’ physiological data directly to healthcare providers.

New approaches in medical education using digital technologies

At the network event, new approaches to education using digital technologies were actively discussed. It has been reported that digital learning, especially in medical disciplines, has significantly increased student satisfaction and improved material acquisition, especially in the context of the COVID-19 pandemic [43]. The introduction of AI, including technologies such as ChatGPT, is transforming medical education and clinical management, but requires caution when applying [4446]. Concerns have been noted regarding ChatGPT’s ability to generate inaccurate medical and scientific data, including non-existent citations [47]. This can lead to the dissemination of inaccurate information and requires special attention when using such technologies.

Digital technologies in drug development and pharmacovigilance

Special attention was given to the digital aspects of drug development. Tools for molecular modeling and virtual screening were presented, which contribute to more efficient drug design [48]. It was reported that molecular docking and in vitro studies of two new TOP2β inhibitors were conducted and yielded interesting outcomes. Despite good binding affinity, the studied compounds were less effective in inhibiting cellular proliferation compared to etoposide [49]. The potential of digital technologies for preventing drug side effects at various stages of pharmaceutical development, including molecular design, ML, and others, was highlighted [50]. A developed BERT model for extracting data on drug side effects from social media was reported, enhancing pharmacovigilance [51]. AI is also being actively used to optimize clinical trials, accelerating diagnostic processes and patient management [52]. These advancements open new opportunities for improving treatment efficacy and patient safety.

Implementing AI in health insurance

Questions have been raised about the implementation of AI to predict health insurance claims [53]. Key factors such as smoking, body mass index, and blood pressure have been identified as affecting forecasting, which could lead to cost savings for insurance companies.

Patient safety and quality of care

The topic of the network event also included issues of patient safety and improving the quality of treatment. One post highlighted research in Austrian hospitals that identified key factors affecting patient safety, such as open communication and executive actions, and showed differences in perceptions of safety culture among doctors, nurses, and other staff groups. The results confirmed that the safety culture has significant potential for improvement and recommended evidence-based practices to improve safety and treatment outcomes [54]. Considering the use of digital technologies in long-term care facilities for the elderly, the authors note that text processing and ML improve the quality of care and contribute to more informed decision-making [55].

One important aspect of the discussion has been obesity research, which is associated with endocrine, genetic, and metabolic disorders that increase the risk of cardiovascular disease and diabetes, which requires an integrated approach to treatment and prevention [56]. Monkeypox prevention measures were also considered, including understanding transmission mechanisms and developing effective vaccines [57].

The network event also actively discussed key studies and new approaches in the treatment and diagnosis of neurological diseases. One interesting post addressed the role of brain connectivity disruptions, as seen in magnetic resonance imaging scans, as precursors to dementia [58]. Special attention was given to the study of the impact of diet on the development of neurodegenerative diseases. Adherence to a Mediterranean diet was found to be associated with improved cognitive functions, particularly in individuals at risk of Alzheimer’s disease [59]. Additionally, data were presented on the significance of natural compounds in the treatment of neurodegenerative diseases. The use of phytochemicals from plants and aquatic organisms, combined with nanotechnology, opens new prospects for enhancing the therapy of these diseases [60]. New therapeutic approaches to the treatment of depression were also discussed. Augmented depression therapy (ADepT) showed higher effectiveness than cognitive-behavioral therapy, particularly in terms of improving well-being and reducing depressive symptoms [61]. Clinical trial results were also presented, showing the positive effects of probiotics and prebiotics on the psycho-emotional state of patients with depression. These data highlighted the importance of maintaining a healthy microbiome for the prevention and treatment of mental health disorders [62]. The role of social interactions in maintaining physical and mental health was also discussed. Research demonstrated that having social connections significantly contributes to better health, while social isolation can have a destructive impact on the body [63]. Furthermore, the experience of using the Calm mobile app to reduce stress in students was presented [64].

Participants in the networking event actively discussed research on natural compounds with various biological activities. Thus, the health benefits of anthocyanins contained in grapes, various berries, rice, corn, potatoes, and other products [25] are reported. The results of studies concerning the beneficial properties of Syzygium jambos fruits and seeds [65] are also presented. Analgesic and anti-inflammatory effects of Aerva javanica extracts [66] were found. The immunomodulatory effect of rosmarinic acid from Punica granatum [67] and the antioxidant and anti-inflammatory properties of saffron [68] have been reported. In addition, data are provided on synthesized O-alkyl derivatives of organic acids that have demonstrated antioxidant properties and the ability to protect dietary fats from oxidation, which opens up prospects for improving the quality of food [69].

Search for partners and vacancies in the scientific field

The networking event discussed finding collaborative partners and jobs, and featured research award opportunities such as the 2024 Young Investigator Award (2,000 CHF; Application Deadline 31 December 2024), a PhD position within the natural products research laboratory at the University of Strathclyde, a PhD studentship in the Centre for Skin Sciences, University of Bradford, the Patchwork Health Clinical Fellowship Program, and a project assistant position (Department of Biological Sciences & Biotechnology, Faculty of Science & Technology, UKM), and a PhD position in AI/ML Algorithms for 6G Telemetry Systems (Netherlands), and a specialist job opening in textual analysis for creating collaborations, etc.

Announcements of special issues and scientific journals

Participants in the network event paid special attention to the announcements of special issues of the journals, such as “Insight in Pharmacological Treatment of Pain” in the journal Frontiers in Pain Research, “Exploration of Digital Health Technologies”, Special Issue “Applications of Cheminformatics and Machine Learning in Predictive Modeling of Property and Toxicity Endpoints of Nanoparticles” in Computational and Structural Biotech Journal, Biomolecules Special Issue “Therapeutic Potential of Natural Products in Metabolic Diseases”; Pharmaceutics Special Issue “Computational Intelligence Tools in Applications of Pharmaceutics”, etc. In addition, book and patent publications were presented, as well as information on changes to the JCR list in 2024.

Announcements about scientific events and conferences

The network event posts featured announcements of seminars, lectures, and conferences such as AARM 2024, 1st International Conference on Autism Advanced Research and Management in Athens, 27th Annual National Convention of the Association of Pharmaceutical Teachers of India (APTICON-2024), and UCL Open Science Conference 2024, among others.

Other digital health solutions

Various digital health technologies and developments were also highlighted, such as Liminal VR virtual reality to improve learning and corporate health, the NaviCam system for non-invasive stomach exams, and the BMind smart mirror using AI to improve mental health. In addition, best practices in chemical characterization of plant extracts and safe digital health monitoring solutions [70], and a video regarding early detection of colorectal cancer, among others, were discussed.

Overall, the event posts referenced several cutting-edge technologies across various healthcare domains. For example, Liminal VR, a virtual reality platform for improving learning in corporate health training, illustrates how immersive technology can be leveraged in healthcare professional education and workplace wellness. Also highlighted was the NaviCam system, an ingestible capsule endoscopy device for non-invasive stomach examinations, reflecting an advancement in gastroenterology that enhances patient comfort and safety by avoiding traditional endoscopy procedures. Similarly, the BMind smart mirror, which uses AI to support mental health, was noted as an unobtrusive digital tool to monitor and promote wellbeing in everyday settings. Participants also shared best-practice guidelines [70] for safe digital health monitoring and a video on early detection of colorectal cancer. This sharing of resources demonstrates how the community used the #DHPSP2024 event not only to spotlight new technologies but also to disseminate knowledge and raise awareness about patient safety practices (for example, standardizing approaches to digital health research and promoting important public health messages).

Interpretation of key insights and practical implications

A key observation from the event’s data is the prominence of telemedicine and AI in the conversations. This suggests a collective recognition among participants that these technologies are crucial drivers for enhancing patient safety and healthcare quality. For instance, repeated references to telehealth initiatives indicate its established role in maintaining continuity of care and expanding access to services. Meanwhile, enthusiasm for AI-driven tools—from diagnostics in ophthalmology and oncology to decision-support in mental health—highlights the expectation that intelligent systems will increasingly support clinical decision-making and personalized treatment. These insights align with broader trends in digital health and confirm that global stakeholders are actively focusing on technologies with immediate practical impact.

Another important implication of our findings lies in the distinct ways different social platforms were used during the event. X and LinkedIn served complementary purposes: X facilitated rapid science communication and community building (e.g., sharing research highlights with hashtags like #SciComm), whereas LinkedIn was utilized for professional discourse and networking (e.g., discussions on data science applications and calls for collaboration). This dual-platform dynamic suggests that future digital health networking initiatives can maximize reach and engagement by leveraging each platform’s strengths—using the real-time, inclusive conversations on X to generate interest, and the more formal professional exchanges on LinkedIn to deepen discussions. For event organizers and communicators, understanding this distinction is valuable for tailoring strategies to better connect with the intended audience on each platform.

From a practical perspective, our analysis provides a snapshot of emerging priorities in the digital health and patient safety landscape. The wide geographic participation (posts from 38 countries) underscores that improving patient safety through digital innovation is a globally shared concern, and it demonstrates how social media can bridge diverse regions in health discussions. Readers can glean which areas—such as telecardiology, AI-powered diagnostics, IoMT for chronic care, and VR-based health training—are currently capturing the community’s attention and investment. Such awareness can help healthcare professionals and policymakers recognize promising digital solutions and identify opportunities for collaboration. For example, the strong interest in telemedicine even after the acute phase of the pandemic suggests that health systems should continue integrating virtual care into standard practice. Similarly, the community’s enthusiasm for novel AI tools may encourage targeted research funding and cross-disciplinary partnerships to further develop and implement these innovations.

Finally, we acknowledge the limitations of using social media content as research data when interpreting our findings. Our analysis captures participants’ engagement and perspectives during a networking event, which offers insight into community interests but does not directly measure the real-world effectiveness or outcomes of the technologies discussed. Accordingly, we have confined our conclusions to describing how the digital health community interacted and what topics were trending, rather than making broad generalizations about healthcare impact. This approach ensures our interpretations remain grounded in the available data and avoids overstating the implications.

Despite these limitations, we believe that capturing this moment in the digital health discourse is valuable. By identifying what experts and stakeholders found noteworthy during #DHPSP2024, our study provides an early indicator of where innovation and collaboration efforts are headed in this field. In adopting this balanced approach, we aim to offer meaningful insights to readers while maintaining appropriate caution.

Looking forward: advancing digital health through policy, ethics, and global collaboration

As digital health technologies continue to evolve, their integration into healthcare systems is expected to accelerate, transforming care delivery toward a more personalized, predictive, and participatory model. AI will likely expand its role in diagnostics, decision support, and administrative automation, while digital therapeutics and remote monitoring tools will enhance chronic disease management and early intervention strategies [29]. However, these advances bring complex challenges that must be addressed to ensure equitable and ethical adoption. Ensuring health equity—especially among underserved populations with limited digital access or literacy—remains a top priority, alongside safeguarding cybersecurity and data privacy in increasingly interconnected health ecosystems [6, 50]. Regulatory systems must also adapt to assess the safety, efficacy, and interoperability of rapidly emerging tools such as AI algorithms and wearable devices [34]. Furthermore, ethical concerns, including algorithmic bias, transparency, and patient autonomy, demand frameworks that promote inclusivity, informed consent, and accountability in digital applications [47, 71]. Global and cross-sectoral collaboration will be pivotal in addressing these concerns. Initiatives such as the WHO’s Global Initiative on Digital Health (GIDH) and the Global Digital Health Partnership (GDHP) exemplify efforts to align digital health strategies, infrastructure, and policy at a transnational level [72, 73]. These platforms aim to support countries in moving from fragmented pilot projects to sustainable digital ecosystems, ensuring that innovations translate into safer, more effective, and more accessible care. The insights gained from the #DHPSP2024 event underscore the need to proactively anticipate these dynamics, enabling the digital health community to shape a future that is not only technologically advanced but also ethically responsible and globally inclusive.

Conclusions

Based on the results of the network event, the following conclusions and recommendations can be made. The networking event facilitated the exchange of ideas and experiences, providing opportunities for participants to find collaborators, collaborative projects, and to strengthen scientific ties. This stimulates the formation of new models of digital health and the introduction of advanced solutions to improve patient safety and quality of care. The data obtained can be used to develop educational programs, improve digital interfaces, implement AI solutions, and create patient safety monitoring platforms.

The application of the principles of open innovation within the event accelerated the process of finding and implementing new ideas, which might be significantly surpassing the traditional “closed” model of innovation in speed and efficiency. In addition, the event has become a source of motivation for researchers. The opportunity to present their scientific works to the scientific community will contribute to their wide distribution and increased visibility, which might have a positive effect on future citations of scientific publications. Messages about upcoming conferences will allow participants to expand their professional knowledge and improve their skills. The DHPSP platform benefited from the additional networking opportunities that will hopefully promote further fruitful cooperation, with the potential to contribute to the successful implementation of future digital health and patient safety solutions.

Abbreviations

AI/ML: artificial intelligence/machine learning

DHPSP: Digital Health and Patient Safety Platform

INPST: International Natural Product Sciences Taskforce

IoMT: Internet of Medical Things

WHO: World Health Organization

Declarations

Acknowledgments

The authors express their sincere gratitude to the participants of the #DHPSP2024 event for their active engagement and significant contributions to the content analyzed in this study.

Author contributions

OL: Conceptualization, Methodology, Formal analysis, Investigation, Writing—original draft. MEM: Conceptualization, Methodology, Formal analysis, Investigation, Writing—review & editing. MM: Formal analysis, Investigation, Writing—review & editing. LBI: Formal analysis, Investigation, Writing—review & editing. EO: Conceptualization, Methodology, Visualization, Writing—review & editing. AGA: Conceptualization, Methodology, Formal analysis, Investigation, Writing—original draft. AWKY, JE, YK, MMR, ZS, KL, BS, AK, AOA, CVS, HKB, FMU, SMSI, JKP, GD, GV, HC, JN, AF, AGG, MRS, DEE, KOA, Michał Ł, YQ, EBS, G Li, HPD, WM, JGM, NTT, RKG, OA, GK, FBM, BNS, DW, JS, JOH, KW, EDP, A Jóźwik, NK, SBB, BHG, TYW, BSG, Marcin Ł, AS, FS, STW, RL, FAN, RKS, AM, HM, A Juhi, SM, M Cenanovic, CT, R De, SSC, R Damaševičius, M Cascella, G Lisco, VT, and OED: Conceptualization, Validation, Writing—review & editing. All authors read and approved the submitted version.

Conflicts of interest

Atanas G. Atanasov is the Editor-in-Chief of Exploration of Digital Health Technologies. Atanas G. Atanasov is an Advisory Board member of QluPod AG, a health-tech company aiming for the development of innovative telehealth solutions. Yousef Khader, Zafar Said, Josef Niebauer, Alexandros G. Georgakilas, and Eliana B. Souto are Associate Editors of Exploration of Digital Health Technologies. Sheikh Mohammed Shariful Islam, Mohammad Reza Saeb, and Jamballi G. Manjunatha are both Associate Editors and Guest Editors of Exploration of Digital Health Technologies. Andy Wai Kan Yeung, Md. Mostafizur Rahman, Anastasios Koulaouzidis, Adeyemi O. Aremu, Ganesh Venkatachalam, Hari Prasad Devkota, Nikolay T. Tzvetkov, Dongdong Wang, Jivko Stoyanov, Emil D. Parvanov, and Marco Cascella are Editorial Board members of Exploration of Digital Health Technologies. Robertas Damaševičius is a Guest Editor of Exploration of Digital Health Technologies. Atanas G. Atanasov, all the Editorial Board members, Associate Editors, and Guest Editors mentioned above had no involvement in the decision-making or the review process of this manuscript. The other authors declare that they have no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

The data analyzed for this study are included in the manuscript, and additional information can be obtained from the corresponding authors upon request.

Funding

AGG acknowledges funding from project BIOSPHERE [No. 21GRD02] that has received funding from the European Partnership on Metrology, co-financed by the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States. This work was supported by the Sichuan Science and Technology Program (Grant No. [2025YFHZ0213]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

© The Author(s) 2025.

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Labrique A, Vasudevan L, Mehl G, Rosskam E, Hyder AA. Digital Health and Health Systems of the Future. Glob Health Sci Pract. 2018;6:S14. [DOI] [PubMed] [PMC]
Atanasov AG. Exploration of Digital Health Technologies. Explor Digit Health Technol. 2023;1:13. [DOI]
Aapro M, Bossi P, Dasari A, Fallowfield L, Gascón P, Geller M, et al. Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Support Care Cancer. 2020;28:4589612. [DOI] [PubMed] [PMC]
Gunasekeran DV, Tseng RMWW, Tham Y, Wong TY. Applications of digital health for public health responses to COVID-19: a systematic scoping review of artificial intelligence, telehealth and related technologies. NPJ Digit Med. 2021;4:40. [DOI] [PubMed] [PMC]
Solomon DH, Rudin RS. Digital health technologies: opportunities and challenges in rheumatology. Nat Rev Rheumatol. 2020;16:52535. [DOI] [PubMed]
Chen C, Ding S, Wang J. Digital health for aging populations. Nat Med. 2023;29:162330. [DOI] [PubMed]
Patel S, Akhtar A, Malins S, Wright N, Rowley E, Young E, et al. The Acceptability and Usability of Digital Health Interventions for Adults With Depression, Anxiety, and Somatoform Disorders: Qualitative Systematic Review and Meta-Synthesis. J Med Internet Res. 2020;22:e16228. [DOI] [PubMed] [PMC]
Alotaibi YK, Federico F. The impact of health information technology on patient safety. Saudi Med J. 2017;38:117380. [DOI] [PubMed] [PMC]
Prelaj A, Miskovic V, Zanitti M, Trovo F, Genova C, Viscardi G, et al. Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review. Ann Oncol. 2024;35:2965. [DOI] [PubMed]
World Health Organization. Global patient safety report 2024. Geneva: World Health Organization; 2024.
Seventy-second World Health Assembly adopted resolution WHA72.6 on “Global action on patient safety” in May 2019 [Internet]. World Health Organization; [cited 2025 May 18]. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA72/A72_R6-en.pdf?ua=1
World Health Organization. Global Strategy on Digital Health 2020-2025. Geneva: World Health Organization; 2021.
Yeung AWK, Atanasov AG, Sheridan H, Klager E, Eibensteiner F, Völkl-Kernsock S, et al. Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis. Front Pharmacol. 2021;11:587526. [DOI] [PubMed] [PMC]
Chesbrough H. To recover faster from Covid-19, open up: Managerial implications from an open innovation perspective. Ind Mark Manage. 2020;88:4103. [DOI]
Orlando B, Ballestra LV, Magni D, Ciampi F. Open innovation and patenting activity in health care. J Intellect Capital. 2021;22:384402. [DOI]
Kletecka-Pulker M, Mondal H, Wang D, Parra RG, Maigoro AY, Lee S, et al. Impacts of biomedical hashtag-based Twitter campaign: #DHPSP utilization for promotion of open innovation in digital health, patient safety, and personalized medicine. Curr Res Biotechnol. 2021;3:14653. [DOI]
Singla RK, De R, Efferth T, Mezzetti B, Uddin MS, Sanusi, et al. The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis. Phytomedicine. 2023;108:154520. [DOI] [PubMed]
Caravaggi A, Olin AB, Franklin KA, Dudley SP. Twitter conferences as a low‐carbon, far‐reaching and inclusive way of communicating research in ornithology and ecology. Ibis. 2021;163:148191. [DOI]
Cheung B, Wong CL, Gardhouse A, Frank C, Budd L. #CGS2015: An Evaluation of Twitter Use at the Canadian Geriatrics Society Annual Scientific Meeting. Can Geriatr J. 2018;21:16672. [DOI] [PubMed] [PMC]
Mihailidou AS, McCall D, Hiremath S, Costello B, Tunuguntla A, Mihailidis H. Use of Social Media at Cardiovascular Congresses: Opportunities for Education and Dissemination. Curr Cardiol Rev. 2021;17:12936. [DOI] [PubMed] [PMC]
Loeb S, Carrick T, Frey C, Titus T. Increasing Social Media Use in Urology: 2017 American Urological Association Survey. Eur Urol Focus. 2020;6:6058. [DOI] [PubMed]
Hong FC, Devine P, McDonald JJ, Cologne K, Brady RRW. Social media engagement amongst 2017 colorectal surgery Tripartite Meeting attendees: updates on contemporary social media use. Colorectal Dis. 2018;20:O1148. [DOI] [PubMed]
Encarnacion Ramirez MJ, Mukengeshay JN, Chumtin G, Nurmukhametov R, Baldoncini M, Lafuente J, et al. The importance of social networks in neurosurgery training in low/middle income countries. Front Surg. 2024;11:1341148. [DOI] [PubMed] [PMC]
Yeung AWK, Litvinova O, Bragazzi NL, Khader Y, Rahman MM, Said Z, et al. Digital health and mobile health: a bibliometric analysis of the 100 most cited papers and their contributing authors. Explor Digit Health Technol. 2024;2:86100. [DOI]
Yeung AWK, Solka M, Jóźwik A, Ksepka N, Matin M, Wang D, et al. Anthocyanins - dietary natural products with a variety of bioactivities for the promotion of human and animal health. Anim Sci Pap Rep. 2024;42:534. [DOI]
Yeung AWK, Ksepka N, Matin M, Wang D, Souto EB, Stoyanov J, et al. Dietary factors in nonalcoholic fatty liver disease: impacts on human and animal health - a review. Anim Sci Pap Rep. 2023;41:17994. [DOI]
Borges do Nascimento IJ, Abdulazeem H, Vasanthan LT, Martinez EZ, Zucoloto ML, Østengaard L, et al. Barriers and facilitators to utilizing digital health technologies by healthcare professionals. NPJ Digit Med. 2023;6:161. [DOI] [PubMed] [PMC]
D’Anza B, Pronovost PJ. Digital Health: Unlocking Value in a Post-Pandemic World. Popul Health Manage. 2022;25:1122. [DOI]
Yeung AWK, Torkamani A, Butte AJ, Glicksberg BS, Schuller B, Rodriguez B, et al. The promise of digital healthcare technologies. Front Public Health. 2023;11:1196596. [DOI] [PubMed] [PMC]
Lordan R, Devkota HP. Turbulence at Twitter with leadership change: implications for health research and science communication. Explor Digit Health Technol. 2023;1:410. [DOI]
Nawaz FA, Riaz MMA, Tsagkaris C, Faisal UH, Klager E, Kletecka-Pulker M, et al. Impact of #PsychTwitter in promoting global psychiatry: A hashtag analysis study. Front Public Health. 2023;11:1065368. [DOI] [PubMed] [PMC]
Matin M, Joshi T, Greger M, Matin FB, Jóźwik A, Wierzbicka A, et al. Use of #NutritionFacts to promote evidence-based nutrition information: X (formerly Twitter) hashtag analysis study. Front Public Health. 2023;11:1255706. [DOI] [PubMed] [PMC]
Wang MH, Xing L, Pan Y, Gu F, Fang J, Yu X, et al. AI-Based Advanced Approaches and Dry Eye Disease Detection Based on Multi-Source Evidence: Cases, Applications, Issues, and Future Directions. Big Data Min Anal. 2024;7:44584. [DOI]
Widman AJ, Shah M, Frydendahl A, Halmos D, Khamnei CC, Øgaard N, et al. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment. Nat Med. 2024;30:165566. [DOI] [PubMed] [PMC]
Tsagkaris C, Matiashova L, Papazoglou AS, Moysidis DV, Loudovikou A, Alexiou A, et al. Telecardiology in the Era of COVID-19: Slaying the Lernaen Hydra of Cardiovascular Disease with the Assistance of a Post-modern Iolaus. Indo Global J Pharm Sci. 2022;12:1104. [DOI]
Pillon S, Gomatou G, Dimakakos E, Stanek A, Pecsvarady Z, Kozak M, et al. A RAND/UCLA-Modified VAS Study on Telemedicine, Telehealth, and Virtual Care in Daily Clinical Practice of Vascular Medicine. J Clin Med. 2024;13:1750. [DOI] [PubMed] [PMC]
Eitenberger M, Gerger G, Klomfar S, Gabriel MA, Kletecka-Pulker M, Schaden E, et al. Focusing on experts: Expectations of healthcare professionals regarding the use of telemedicine in intensive care units. Digit Health. 2024;10:20552076241257042. [DOI] [PubMed] [PMC]
Khan S, Kandukuri DK, Subramaniyan EU, MohanaSundaram A. Harnessing the untapped potential of digital twin technology in digital public health interventions. Explor Digit Health Technol. 2023;1:116. [DOI]
Litvinova O, Eitenberger M, Bilir A, Yeung AWK, Parvanov ED, MohanaSundaram A, et al. Patent analysis of digital sensors for continuous glucose monitoring. Front Public Health. 2023;11:1205903. [DOI] [PubMed] [PMC]
Litvinova O, Bilir A, Parvanov ED, Niebauer J, Kletecka-Pulker M, Kimberger O, et al. Patent landscape review of non-invasive medical sensors for continuous monitoring of blood pressure and their validation in critical care practice. Front Med (Lausanne). 2023;10:1138051. [DOI] [PubMed] [PMC]
Hershcovitz Y, Breuer Asher I, Manejwala O. 1012-P: Deep Sleep Interaction with Blood Glucose Levels in People Using an Integrated Digital Health Platform for Diabetes Management. Diabetes. 2024;73:1012-P. [DOI]
Litvinova O, Klager E, Tzvetkov NT, Kimberger O, Kletecka-Pulker M, Willschke H, et al. Digital Pills with Ingestible Sensors: Patent Landscape Analysis. Pharmaceuticals (Basel). 2022;15:1025. [DOI] [PubMed] [PMC]
Yeung AWK, Parvanov ED, Hribersek M, Eibensteiner F, Klager E, Kletecka-Pulker M, et al. Digital Teaching in Medical Education: Scientific Literature Landscape Review. JMIR Med Educ. 2022;8:e32747. [DOI] [PubMed] [PMC]
Khan RA, Jawaid M, Khan AR, Sajjad M. ChatGPT - Reshaping medical education and clinical management. Pak J Med Sci. 2023;39:6057. [DOI] [PubMed] [PMC]
Chakraborty C, Bhattacharya M, Pal S, Lee SS. From machine learning to deep learning: Advances of the recent data-driven paradigm shift in medicine and healthcare. Curr Res Biotechnol. 2024;7:100164. [DOI]
Abavisani M, Khoshrou A, Karbas Foroushan S, Sahebkar A. Chatting with artificial intelligence to combat antibiotic resistance: Opportunities and challenges. Curr Res Biotechnol. 2024;7:100197. [DOI]
Clelland CL, Moss S, Clelland JD. Warning: Artificial intelligence chatbots can generate inaccurate medical and scientific information and references. Explor Digit Health Technol. 2024;2:16. [DOI]
Patel JR, Joshi HV, Shah UA, K. Patel J. A Review on Computational Software Tools for Drug Design and Discovery. Indo Global J Pharm Sci. 2022;12:5381. [DOI]
Peeva MI, Georgieva MG, Balacheva AA, Ponticelli M, Bogdanov IP, Kolev T, et al. Crystal Structures, Molecular Docking and In Vitro Investigations of Two 4-Substituted 2-(5,5-dimethyl-3-styrylcyclohex-2-enylidene)malononitrile Derivatives as Potential Topoisomerase II Inhibitors. Crystals. 2024;14:496. [DOI]
Litvinova O, Yeung AWK, Hammerle FP, Mickael M, Matin M, Kletecka-Pulker M, et al. Digital Technology Applications in the Management of Adverse Drug Reactions: Bibliometric Analysis. Pharmaceuticals (Basel). 2024;17:395. [DOI] [PubMed] [PMC]
Dong F, Guo W, Liu J, Patterson TA, Hong H. BERT-based language model for accurate drug adverse event extraction from social media: implementation, evaluation, and contributions to pharmacovigilance practices. Front Public Health. 2024;12:1392180. [DOI] [PubMed] [PMC]
Chopra H, Annu, Shin DK, Munjal K, Priyanka, Dhama K, et al. Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs. Int J Surg. 2023;109:421120. [DOI] [PubMed] [PMC]
Alam A, Prybutok VR. Use of responsible artificial intelligence to predict health insurance claims in the USA using machine learning algorithms. Explor Digit Health Technol. 2024;2:3045. [DOI]
Draganović Š, Offermanns G. Patient safety culture in Austria and recommendations of evidence-based instruments for improving patient safety. PLoS One. 2022;17:e0274805. [DOI]
Hendriks A, Hacking C, Verbeek H, Aarts S. Data science techniques to gain novel insights into quality of care: a scoping review of long-term care for older adults. Explor Digit Health Technol. 2024;2:6785. [DOI]
Das B, Khaled KL. Pathophysiology of obesity: An extensive review. Indo Global J Pharm Sci. 2024;14:131. [DOI]
Sultana A, Sultana A, Shawon NJ, Kabir S, Chowdhury AA, Amran MS. Monkeypox: In Quest of Effective Vaccines. Indo Global J Pharm Sci. 2024;14:1124. [DOI]
Ereira S, Waters S, Razi A, Marshall CR. Early detection of dementia with default-mode network effective connectivity. Nat Mental Health. 2024;2:787800. [DOI]
Ballarini T, Melo van Lent D, Brunner J, Schröder A, Wolfsgruber S, Altenstein S, et al. Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age. Neurology. 2021;96:e292032. [DOI] [PubMed] [PMC]
Goyal R, Mittal P, Gautam RK, Kamal MA, Perveen A, Garg V, et al. Natural products in the management of neurodegenerative diseases. Nutr Metab (Lond). 2024;21:26. [DOI] [PubMed] [PMC]
Dunn BD, Widnall E, Warbrick L, Warner F, Reed N, Price A, et al. Preliminary clinical and cost effectiveness of augmented depression therapy versus cognitive behavioural therapy for the treatment of anhedonic depression (ADepT): a single-centre, open-label, parallel-group, pilot, randomised, controlled trial. EClinicalMedicine. 2023;61:102084. [DOI] [PubMed] [PMC]
Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clin Nutr. 2019;38:5228. [DOI] [PubMed]
Martino J, Pegg J, Frates EP. The Connection Prescription: Using the Power of Social Interactions and the Deep Desire for Connectedness to Empower Health and Wellness. Am J Lifestyle Med. 2015;11:46675. [DOI] [PubMed] [PMC]
Huberty J, Green J, Glissmann C, Larkey L, Puzia M, Lee C. Efficacy of the Mindfulness Meditation Mobile App “Calm” to Reduce Stress Among College Students: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019;7:e14273. [DOI] [PubMed] [PMC]
Dutta S, Khaled KL. Quantitative Estimation and Comparative Analysis of Mineral Content of Syzygium jambos Fruit and Its Seed. Indo Global J Pharm Sci. 2021;11:14753. [DOI]
Swarnkar SK, Khunteta A, Gupta MK, Jain P, Sharma S, Paliwal S. Antinociceptive activity shown by Aerva javanica flowering top extract and its mechanistic evaluation. Indo Global J Pharm Sci. 2021;11:3341. [DOI]
Gautam RK, Tripathi SM, Akash S, Sharma S, Sharma K, Goyal S, et al. Unlocking the Immunomodulatory Potential of Rosmarinic Acid Isolated from Punica granatum L. using Bioactivity-Guided Approach: In Silico, In Vitro, and In Vivo Approaches. Curr Med Chem. 2024;31:596988. [DOI] [PubMed]
Elfardi YR, El Boukhari R, Fatimi A, Bouissane L. The Multifaceted Therapeutic Potential of Saffron: An Overview Based on Research and Patents. Drugs Drug Candidates. 2024;3:43754. [DOI]
Forero-Doria O, Guzmán L, Venturini W, Zapata-Gomez F, Duarte Y, Camargo-Ayala L, et al. O-Alkyl derivatives of ferulic and syringic acid as lipophilic antioxidants: effect of the length of the alkyl chain on the improvement of the thermo-oxidative stability of sunflower oil. RSC Adv. 2024;14:2251324. [DOI] [PubMed] [PMC]
Heinrich M, Jalil B, Abdel-Tawab M, Echeverria J, Kulić Ž, McGaw LJ, et al. Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research—The ConPhyMP—Guidelines. Front Pharmacol. 2022;13:953205. [DOI]
World Health Organization. Ethics and Governance of Artificial Intelligence for Health. Geneva: World Health Organization; 2021.
Global Initiative on Digital Health [Internet]. World Health Organization; c2025 [cited 2025 May 18]. Available from: https://www.who.int/initiatives/global-initiative-on-digital-health
Global Digital Health Partnership [Internet]. Global Digital Health Partnership; c2024 [cited 2025 May 18]. Available from: https://gdhp.health/
Cite this Article
Export Citation
Litvinova O, Yeung AWK, Echeverría J, Khader Y, Rahman MM, Said Z, et al. Global innovative perspectives and trends on digital health and patient safety: highlights from the #DHPSP2024 networking event. Explor Digit Health Technol. 2025;3:101166. https://doi.org/10.37349/edht.2025.101166
Article Metrics

View: 33

Download: 6

Times Cited: 0